Experimental Drug Targets HIV in a Novel Way

At the ALS, researchers studied how an experimental HIV drug targets a type of protein that forms a shield around the viral RNA. The work could lead to a long-lasting HIV treatment that overcomes the problem of drug resistance and avoids the need for daily pill-taking. https://als.lbl.gov/experimental-drug-targets-hiv-in-a-novel-way/